BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 32234488)

  • 1. LIN28B Underlies the Pathogenesis of a Subclass of Ewing Sarcoma LIN28B Control of EWS-FLI1 Stability.
    Keskin T; Bakaric A; Waszyk P; Boulay G; Torsello M; Cornaz-Buros S; Chevalier N; Geiser T; Martin P; Volorio A; Iyer S; Kulkarni A; Letovanec I; Cherix S; Cote GM; Choy E; Digklia A; Montemurro M; Chebib I; Nielsen PG; Carcaboso AM; Mora J; Renella R; Suvà ML; Fusco C; Provero P; Rivera MN; Riggi N; Stamenkovic I
    Cell Rep; 2020 Mar; 30(13):4567-4583.e5. PubMed ID: 32234488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma.
    Grohar PJ; Kim S; Rangel Rivera GO; Sen N; Haddock S; Harlow ML; Maloney NK; Zhu J; O'Neill M; Jones TL; Huppi K; Grandin M; Gehlhaus K; Klumpp-Thomas CA; Buehler E; Helman LJ; Martin SE; Caplen NJ
    Cell Rep; 2016 Jan; 14(3):598-610. PubMed ID: 26776507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPOP and OTUD7A Control EWS-FLI1 Protein Stability to Govern Ewing Sarcoma Growth.
    Su S; Chen J; Jiang Y; Wang Y; Vital T; Zhang J; Laggner C; Nguyen KT; Zhu Z; Prevatte AW; Barker NK; Herring LE; Davis IJ; Liu P
    Adv Sci (Weinh); 2021 Jul; 8(14):e2004846. PubMed ID: 34060252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EWS-FLI1 regulates and cooperates with core regulatory circuitry in Ewing sarcoma.
    Shi X; Zheng Y; Jiang L; Zhou B; Yang W; Li L; Ding L; Huang M; Gery S; Lin DC; Koeffler HP
    Nucleic Acids Res; 2020 Nov; 48(20):11434-11451. PubMed ID: 33080033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor.
    Osgood CL; Maloney N; Kidd CG; Kitchen-Goosen S; Segars L; Gebregiorgis M; Woldemichael GM; He M; Sankar S; Lessnick SL; Kang M; Smith M; Turner L; Madaj ZB; Winn ME; Núñez LE; González-Sabín J; Helman LJ; Morís F; Grohar PJ
    Clin Cancer Res; 2016 Aug; 22(16):4105-18. PubMed ID: 26979396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization.
    Pedot G; Marques JG; Ambühl PP; Wachtel M; Kasper S; Ngo QA; Niggli FK; Schäfer BW
    Neoplasia; 2022 May; 27():100784. PubMed ID: 35366465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EWS-FLI1 reprograms the metabolism of Ewing sarcoma cells via positive regulation of glutamine import and serine-glycine biosynthesis.
    Sen N; Cross AM; Lorenzi PL; Khan J; Gryder BE; Kim S; Caplen NJ
    Mol Carcinog; 2018 Oct; 57(10):1342-1357. PubMed ID: 29873416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells.
    Agra N; Cidre F; García-García L; de la Parra J; Alonso J
    PLoS One; 2013; 8(6):e66281. PubMed ID: 23750284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EWS-FLI1 employs an E2F switch to drive target gene expression.
    Schwentner R; Papamarkou T; Kauer MO; Stathopoulos V; Yang F; Bilke S; Meltzer PS; Girolami M; Kovar H
    Nucleic Acids Res; 2015 Mar; 43(5):2780-9. PubMed ID: 25712098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity.
    Balestra T; Manara MC; Laginestra MA; Pasello M; De Feo A; Bassi C; Guerzoni C; Landuzzi L; Lollini PL; Donati DM; Negrini M; Magnani M; Scotlandi K
    Mol Cancer Ther; 2022 Jan; 21(1):58-69. PubMed ID: 34667115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NELL2-cdc42 signaling regulates BAF complexes and Ewing sarcoma cell growth.
    Jayabal P; Zhou F; Lei X; Ma X; Blackman B; Weintraub ST; Houghton PJ; Shiio Y
    Cell Rep; 2021 Jul; 36(1):109254. PubMed ID: 34233189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex.
    Selvanathan SP; Graham GT; Grego AR; Baker TM; Hogg JR; Simpson M; Batish M; Crompton B; Stegmaier K; Tomazou EM; Kovar H; Üren A; Toretsky JA
    Nucleic Acids Res; 2019 Oct; 47(18):9619-9636. PubMed ID: 31392992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma.
    Yasir M; Park J; Chun W
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP1 Expression Driven by EWS::FLI1 Transcription Factor Stabilizes Survivin and Mitigates Replication Stress in Ewing Sarcoma.
    Mallard HJ; Wan S; Nidhi P; Hanscom-Trofy YD; Mohapatra B; Woods NT; Lopez-Guerrero JA; Llombart-Bosch A; Machado I; Scotlandi K; Kreiling NF; Perry MC; Mirza S; Coulter DW; Band V; Band H; Ghosal G
    Mol Cancer Res; 2023 Nov; 21(11):1186-1204. PubMed ID: 37478161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Chromatin Remodeler CHD4 Sustains Ewing Sarcoma Cell Survival by Controlling Global Chromatin Architecture.
    Graca Marques J; Pavlovic B; Ngo QA; Pedot G; Roemmele M; Volken L; Kisele S; Perbet R; Wachtel M; Schäfer BW
    Cancer Res; 2024 Jan; 84(2):241-257. PubMed ID: 37963210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cadherin-11 contributes to the heterogenous and dynamic Wnt-Wnt-β-catenin pathway activation in Ewing sarcoma.
    Shirai R; Biebighauser T; Walker D; Oviedo J; Nelson-Taylor S; Bodlak A; Porfilio T; Oike N; Goodspeed A; Hayashi M
    PLoS One; 2024; 19(6):e0305490. PubMed ID: 38875295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewing sarcoma.
    Lu DY; Ellegast JM; Ross KN; Malone CF; Lin S; Mabe NW; Dharia NV; Meyer A; Conway A; Su AH; Selich-Anderson J; Taslim C; Byrum AK; Seong BKA; Adane B; Gray NS; Rivera MN; Lessnick SL; Stegmaier K
    Nat Cell Biol; 2023 Feb; 25(2):285-297. PubMed ID: 36658220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel FET-ETS family fusion (FUS::FLI1) in a case of Ewing sarcoma.
    Dorwal P; Lambie D; Dettrick A; Goh AFN; Kumar B; Manders P
    Pathol Int; 2023 Nov; 73(11):563-565. PubMed ID: 37606217
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer-Associated Fibroblast-Like Tumor Cells Remodel the Ewing Sarcoma Tumor Microenvironment.
    Wrenn ED; Apfelbaum AA; Rudzinski ER; Deng X; Jiang W; Sud S; Van Noord RA; Newman EA; Garcia NM; Miyaki A; Hoglund VJ; Bhise SS; Kanaan SB; Waltner OG; Furlan SN; Lawlor ER
    Clin Cancer Res; 2023 Dec; 29(24):5140-5154. PubMed ID: 37471463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DNA/RNA helicase DHX9 orchestrates the KDM2B-mediated transcriptional regulation of YAP1 in Ewing sarcoma.
    Chellini L; Scarfò M; Bonvissuto D; Sette C; Paronetto MP
    Oncogene; 2024 Jan; 43(4):225-234. PubMed ID: 38017132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.